[Prognosis in Alzheimer's disease].
Kitamura
Shin
S
Department of Internal Medicine, Nippon Medical School Second Hospital.
D000203:Activities of Daily Living; D000544:Alzheimer Disease / Q000401:mortality / Q000503:physiopathology / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D000077265:Donepezil; D004359:Drug Therapy, Combination; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008606:Mental Processes; D010880:Piperidines / Q000627:therapeutic use; D011379:Prognosis; D012306:Risk; D012642:Selegiline / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors; D014810:Vitamin E / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D014810:Vitamin E; D012642:Selegiline; D000077265:Donepezil